Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
---|
03/27/2013 | CN101296907B Diaminopyrimidines as P2X3 and P2X2/3 modulators |
03/27/2013 | CN101287721B 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use |
03/27/2013 | CN101273029B Bicyclic bisamide derivatives and use thereof as insecticides |
03/27/2013 | CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors |
03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
03/26/2013 | US8404837 Quinoline derivatives as P13 kinase inhibitors |
03/26/2013 | US8404765 Sterically hindered amines and use thereof as polymer stabilizers |
03/26/2013 | US8404728 Small-molecule botulinum toxin inhibitors |
03/26/2013 | US8404722 Oxazole compounds compositions and methods of use |
03/26/2013 | US8404708 Dual NK1/NK3 receptor antagonists |
03/26/2013 | US8404693 Substituted piperidine compounds and methods of their use |
03/26/2013 | US8404685 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
03/26/2013 | US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
03/26/2013 | US8404676 Oxadiazole diaryl compounds |
03/26/2013 | US8404672 Substituted heterocyclic compounds |
03/26/2013 | CA2531485C Malonamide derivatives |
03/21/2013 | WO2013040044A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
03/21/2013 | WO2013039202A1 Novel acrylic acid derivative |
03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
03/21/2013 | WO2013038386A1 Heterocyclic compounds for the treatment of cystic fibrosis |
03/21/2013 | WO2013037755A1 Plant growth regulating compounds |
03/21/2013 | WO2013037731A1 Novel polymorphic form of raltegravir potassium |
03/21/2013 | WO2013037721A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
03/21/2013 | WO2013037717A1 Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives |
03/21/2013 | WO2013037704A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
03/21/2013 | WO2013037703A1 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
03/21/2013 | WO2012157984A3 Novel heteroaromatic compounds and use thereof |
03/21/2013 | US20130072680 Processes for the preparation of rivaroxaban and intermediates thereof |
03/21/2013 | US20130072679 Dihydroquinoline-2-one derivatives |
03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
03/21/2013 | US20130072523 Analogues for the treatment or prevention of flavivirus infections |
03/21/2013 | US20130072494 Inhibitors of jun n-terminal kinase |
03/21/2013 | US20130072490 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
03/21/2013 | US20130072489 Triazole compounds that modulate hsp90 activity |
03/21/2013 | US20130072488 Aralkyl diamine derivatives and uses thereof as antidepressants |
03/21/2013 | US20130072487 Prolyl hydroxylase inhibitors |
03/21/2013 | US20130072486 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
03/21/2013 | US20130072480 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators |
03/21/2013 | US20130072478 N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl-amides as bace1 inhibitors |
03/21/2013 | US20130072469 Heteroaryl compounds and uses thereof |
03/21/2013 | US20130072468 Substituted piperazines as cb1 antagonists |
03/21/2013 | US20130072461 Triazole compounds that modulate hsp90 activity |
03/21/2013 | US20130072457 Pyrazolyl quinazoline kinase inhibitors |
03/21/2013 | US20130072449 Lysophosphatidic acid receptor antagonists |
03/21/2013 | CA2846779A1 Plant growth regulating compounds |
03/21/2013 | CA2844865A1 3-pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
03/21/2013 | CA2844835A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
03/21/2013 | CA2844834A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
03/21/2013 | CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
03/20/2013 | EP2569313A1 Compounds useful as inhibitors of atr kinase |
03/20/2013 | EP2569312A1 Substituted heterocyclyl benzyl pyrazoles, and use thereof |
03/20/2013 | EP2569311A1 Ambipolar small molecule hosts for phosphorescent guest emitters |
03/20/2013 | EP2569310A1 Morpholine compounds as mineralocorticoid receptor antagonists |
03/20/2013 | EP2569309A1 Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases |
03/20/2013 | EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
03/20/2013 | EP2569305A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
03/20/2013 | EP2569301A1 Indazole inhibitors of kinase |
03/20/2013 | EP2569300A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
03/20/2013 | EP2569291A1 Selective glycosidase inhibitors and uses thereof |
03/20/2013 | EP2569287A2 Compounds useful as inhibitors of atr kinase |
03/20/2013 | EP2569285A1 Bifunctional quinoline derivatives |
03/20/2013 | EP2569284A1 2 -aminopyridine derivatives useful as inhibitors of atr kinase |
03/20/2013 | EP2569280A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
03/20/2013 | EP2125795B1 Indole derivatives |
03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
03/20/2013 | CN102985419A Fungicide hydroximoyl-heterocycles derivatives |
03/20/2013 | CN102985407A 8-hydroxy-quinoline derivatives |
03/20/2013 | CN102977087A Application of selective alpha2A receptor stimulant in treating alzheimer disease |
03/20/2013 | CN102977086A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842 |
03/20/2013 | CN102977085A 2-aryl-benzo[d]oxazole and 2-aryl-benzo[d]thiazole derivatives, and preparation methods and application thereof |
03/20/2013 | CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs |
03/20/2013 | CN102977029A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
03/20/2013 | CN102101852B Coumarin derivates, preparation method thereof and application thereof in white-light organic electroluminescent device |
03/20/2013 | CN102030743B Iloperidone crystal, and preparation method and medicinal composition thereof |
03/20/2013 | CN101466709B 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity |
03/20/2013 | CN101039920B 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
03/19/2013 | US8399681 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
03/19/2013 | US8399673 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators |
03/19/2013 | US8399666 5-lipoxygenase-activating protein (FLAP) inhibitors |
03/19/2013 | US8399660 Process for the synthesis of triazoles |
03/19/2013 | US8399497 Thiazole derivatives and use thereof |
03/19/2013 | US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
03/19/2013 | US8399463 Imidazole derivatives |
03/19/2013 | US8399461 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
03/19/2013 | US8399460 Chromenone derivatives |
03/19/2013 | US8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
03/19/2013 | US8399451 Heterocyclic compounds |
03/19/2013 | US8399450 Compounds and compositions as protein kinase inhibitors |
03/19/2013 | US8399448 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis |
03/19/2013 | US8399436 N-pyrazolyl carboxamides as CRAC channel inhibitors |
03/19/2013 | US8399433 Amino pyrimidine anticancer compounds |
03/19/2013 | CA2682629C Pyrimidine hydrazide compounds as pgds inhibitors |
03/19/2013 | CA2549228C Hiv protease inhibiting compounds |
03/19/2013 | CA2524027C Immunosuppressant compounds and compositions |
03/19/2013 | CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
03/14/2013 | WO2013036671A1 Compounds useful for treating neurodegenerative disorders |
03/14/2013 | WO2013036207A1 Derivatives of xanthone compounds |
03/14/2013 | WO2013036196A1 Novel thiophene compounds and method for in vivo imaging |
03/14/2013 | WO2013035827A1 Novel olefin derivative |